A research framework for reducing preventable patient harm

Clinical Infectious Diseases

Volumn 52, Issue 4, 2011, Pages 507-513

  Pronovost, Peter J ^a,b,c   Cardo, Denise M ^d   Goeschel, Christine A ^a,c   Berenholtz, Sean M ^a,b   Saint, Sanjay ^e   Jernigan, John A ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; POVIDONE IODINE;

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; CONCEPTUAL FRAMEWORK; DISEASE SURVEILLANCE; EVIDENCE BASED PRACTICE; HARM REDUCTION; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFORMATION DISSEMINATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SKIN DECONTAMINATION; SURGICAL INFECTION; TRANSLATIONAL RESEARCH; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

BIOMEDICAL RESEARCH; CROSS INFECTION; GUIDELINES AS TOPIC; HUMANS; IATROGENIC DISEASE;

EID: 79951835511     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq172     Document Type: Article

References (57)

1. Kohn L, Corrigan J, Donaldson M. To err is human: building a safer health system. Institute of Medicine report. Washington, DC: National Academies Press, 1999.
2. Wachter RM. Patient safety at ten: unmistakable progress, troubling gaps. Health Aff (Millwood) 2010;29:165-73.
3. Pronovost PJ, Miller MR, Wachter RM. Tracking progress in patient safety: an elusive target. JAMA 2006;296:696-9. (Pubitemid 44200641)
4. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301:727-36.
5. Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304:641-8.
6. Agency for Healthcare Research Quality (AHRQ). National healthcare quality report 2007. No. 08-0040. Rockville, MD: AHRQ, 2008.
7. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-32. (Pubitemid 46021509)
8. Centers for Disease Control Prevention. Reduction in central lineassociated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:1013-6.
9. Cardo D, Dennehy PH, Halverson P, et al. Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol 2010;31:1101-5.
10. Sawyer M, Weeks K, Goeschel CA, et al. Using evidence, rigorous measurement, and collaboration to eliminate central line-associated bloodstream infections. Crit Care Med 2010;38(8 Suppl) ; S292-8.
11. DePalo VA, McNicoll L, Cornell M, Rocha JM, Adams L, Pronovost PJ. The Rhode Island ICU collaborative: a model for reducing central lineassociated bloodstream infection and ventilator-associated pneumonia statewide. Qual Saf Healthcare 2010;19:555-561.
12. US Department of Health Human Services. HHS action plan to prevent healthcare-associated infections. Washington, DC: Department of Health and Human Services, 2009. Available at: http://www.hhs.gov/ash/initiatives/hai/ actionplan/index.html. Accessed 25 October 2010.
13. Pronovost PJ, Goeschel CA, Olsen KL, et al. Reducing health care hazards: Lessons from the commercial aviation safety team. Health Aff (Millwood) 2009;28: w479-89.
14. Pronovost PJ, Goeschel CA, Marsteller JA, Sexton JB, Pham JC, Berenholtz SM. A framework for patient safety research and improvement. Circulation 2009;119:330-7.
15. Davidoff F. Checklists and guidelines: imaging techniques for visualizing what to do. JAMA 2010;304:206-7.
16. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-74. (Pubitemid 350287151)
17. Institute of Translational Health Sciences. About translational research. Available at: http://www.iths.org/about/translational. Accessed 25 October 2010.
18. Ohio State University Medical Center. Translational research. Available at: http://medicalcenter.osu.edu/research/translational-research/Pages/index. aspx Accessed 25 October 2010.
19. Dougherty D, Conway PH. The "3T's" road map to transform US health care: the "how" of high-quality care. JAMA 2008;299:2319-21. (Pubitemid 351724400)
20. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial and Infections Surveillance System. Am J Med 1991;91:185S-91S.
21. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91:197S-205S.
22. Snydman DR, Gorbea HF, Pober BR, Majka JA, Murray SA, Perry LK. Predictive value of surveillance skin cultures in total-parenteralnutrition- related infection. Lancet 1982;2:1385-8. (Pubitemid 13254796)
23. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998;19:842-5. (Pubitemid 128472206)
24. Ayliffe GA, Babb JR, Davies JG, Lilly HA. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988;11:226-43.
25. Raad I, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions during Insertion. Infec Control Hosp Epidemiol 1994;15:231-8.
26. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.
27. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidoneiodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14:510-6.
28. Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996;24:1818-23. (Pubitemid 26382924)
29. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002;136:792-801. (Pubitemid 34568649)
30. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: The clinical and economic benefits of chlorhexidine gluconate compared to povidone iodine solution. Clin Infect Dis 2003;37:764-71. (Pubitemid 37153654)
31. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 2004;32:142-6. (Pubitemid 38620835)
32. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: The clinical and economic benefits of chlorhexidine gluconate compared to povidone iodine solution. Clin Infect Dis 2003;37:764-71. (Pubitemid 37153654)
33. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;55:1-26.
34. Bent S, Shojania KG, Saint S. The use of systematic reviews and meta-analyses in infection control and hospital epidemiology. Am J Infect Control 2004;32:246-54. (Pubitemid 38857902)
35. Saint S, Chenoweth C, Fendrick AM. The role of economic evaluation in infection control. Am J Infect Control 2001;29:338-44. (Pubitemid 32955079)
36. Perencevich EN, Stone PW, Wright SB, et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121-33. (Pubitemid 47580454)
37. Pronovost PJ, Berenholtz SM, Goeschel C, et al. Improving patient safety in intensive care units in Michigan. J Crit Care 2008;23:207-21.
38. Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010;340: c309.
39. Gurses AP, Murphy DJ, Martinez EA, Berenholtz SM, Pronovost PJ. A practical tool to identify and eliminate barriers to compliance with evidence-based guidelines. Jt Comm J Qual Patient Saf 2009;35:526-32.
40. Pronovost P, Weast B, Rosenstein B, et al. Implementing and validating a comprehensive unit-based safety program. J Patient Saf 2005;1:33-40.
41. Timmel J, Kent PS, Holzmueller CG, Paine LA, Schulick RD, Pronovost PJ. Impact of the Comprehensive Unit-based Safety Program (CUSP) on safety culture in a surgical inpatient unit. Jt Comm J Qual Patient Saf 2010;36:252-60.
42. Pronovost PJ, Holzmueller CG, Martinez E, et al. A practical tool to learn from defects in patient care. Jt Comm J Qual Patient Saf 2006;32:102-8.
43. Pronovost PJ, Weast B, Bishop K, et al. Senior executive adopt-a-work unit: a model for safety improvement. Jt Comm J Qual Saf 2004;30:59-68.
44. Pronovost P, Berenholtz S, Dorman T, Lipsett PA, Simmonds T, Haraden C. Improving communication in the ICU using daily goals. J Crit Care 2003;18:71-5. (Pubitemid 36759157)
45. Weiner BJ. A theory of organizational readiness for change. Implement Sci 2009;4:67.
46. Forman J, Creswell JW, Damschroder L, Kowalski CP, Krein SL. Qualitative research methods: key features and insights gained from use in infection prevention research. Am J Infect Control 2008;36:764-71.
47. Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337:963-5.
48. McCannon CJ, Perla RJ. Learning networks for sustainable, large-scale improvement. Jt Comm J Qual Patient Saf 2009;35:286-91.
49. Centers for Medicare Medicaid Services. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment changes and FY2011 rates. Fed Regist 2010;75:50042-677.
50. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter gram positive infections in oncology patients. Cochrane Database Syst Rev 2007. (1): CD003295.
51. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47:83-93. (Pubitemid 351920592)
52. Gould CV, Umscheid CA, Agarwal RK, Kunt G, Pegues DA, and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for prevention of catheter-associated urinary tract infections, 2009, Atlanta, GA: HICPAC, Centers for Disease Control Prevention, 2009.
53. Saint S, Kowalski CP, Kaufman SR, et al. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis 2008;46:243-50. (Pubitemid 351269163)
54. Saint S, Kowalski CP, Forman J, et al. A multicenter qualitative study on preventing hospital-acquired urinary tract infection in US hospitals. Infect Control Hosp Epidemiol 2008;29:333-41. (Pubitemid 351416984)
55. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for "preventable complications.". JAMA 2008;299:2197-9. (Pubitemid 351679711)
56. Wald HL, Kramer AM. Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections. JAMA 2007;298:2782-4. (Pubitemid 350294301)
57. Saint S, Meddings JA, Calfee D, Kowalski CP, Krein SL. Catheterassociated urinary tract infection and the Medicare rule changes. Ann Intern Med 2009;150:877-84.